CONDORELLI, GEROLAMA
 Distribuzione geografica
Continente #
AS - Asia 6.160
NA - Nord America 5.589
EU - Europa 4.678
SA - Sud America 748
AF - Africa 155
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.348
Nazione #
US - Stati Uniti d'America 5.327
SG - Singapore 2.834
RU - Federazione Russa 1.925
VN - Vietnam 1.121
CN - Cina 1.076
IT - Italia 835
BR - Brasile 617
DE - Germania 548
HK - Hong Kong 467
FI - Finlandia 312
FR - Francia 257
CA - Canada 172
NL - Olanda 161
GB - Regno Unito 133
IE - Irlanda 129
IN - India 125
SE - Svezia 114
UA - Ucraina 106
JP - Giappone 98
BD - Bangladesh 96
AR - Argentina 50
IQ - Iraq 45
MX - Messico 45
CI - Costa d'Avorio 40
PH - Filippine 39
ZA - Sudafrica 37
TH - Thailandia 36
ID - Indonesia 33
TR - Turchia 33
PL - Polonia 32
EC - Ecuador 29
ES - Italia 27
KR - Corea 23
AT - Austria 22
PK - Pakistan 22
LT - Lituania 19
TW - Taiwan 19
UZ - Uzbekistan 16
BE - Belgio 15
CO - Colombia 12
MA - Marocco 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
ET - Etiopia 10
JM - Giamaica 10
KE - Kenya 10
CZ - Repubblica Ceca 9
JO - Giordania 9
PY - Paraguay 9
VE - Venezuela 9
AU - Australia 8
IR - Iran 8
MY - Malesia 8
SA - Arabia Saudita 8
CL - Cile 7
DZ - Algeria 7
BG - Bulgaria 6
SN - Senegal 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
NP - Nepal 5
NZ - Nuova Zelanda 5
RS - Serbia 5
UY - Uruguay 5
IL - Israele 4
RO - Romania 4
CR - Costa Rica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
EE - Estonia 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
MD - Moldavia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
TG - Togo 2
ZW - Zimbabwe 2
AL - Albania 1
AM - Armenia 1
BF - Burkina Faso 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
Totale 17.318
Città #
Singapore 1.307
San Jose 919
Ashburn 471
Chandler 453
Hong Kong 452
Moscow 431
Ho Chi Minh City 329
Beijing 317
Munich 290
Santa Clara 259
Hanoi 237
Naples 181
The Dalles 165
Millbury 149
Amsterdam 146
Lauterbourg 140
Jacksonville 136
Helsinki 135
Princeton 129
Napoli 126
Los Angeles 122
Dallas 120
Boston 105
Nanjing 98
Ottawa 92
Hefei 86
Rome 85
Tokyo 82
Wilmington 82
Buffalo 81
New York 73
Frankfurt am Main 61
São Paulo 55
Haiphong 50
Des Moines 47
Turku 45
Da Nang 44
Nanchang 40
Dong Ket 36
Redondo Beach 36
Shenyang 34
Council Bluffs 33
Houston 33
Seattle 32
Pune 31
Montreal 30
Milan 27
Orem 27
Toronto 27
Nuremberg 26
Dublin 25
Lawrence 25
Cagliari 24
Chennai 24
Warsaw 24
Denver 23
Redwood City 23
Chicago 22
Falls Church 22
Hebei 22
Jiaxing 22
Rio de Janeiro 22
San Giorgio del Sannio 22
Johannesburg 21
Atlanta 20
Brooklyn 20
London 20
Tianjin 20
Baghdad 18
Can Tho 18
Washington 18
Changsha 17
Falkenstein 17
Woodbridge 17
Phoenix 16
Poplar 16
Brasília 15
Manchester 15
Mexico City 15
Verona 15
Biên Hòa 14
Shanghai 14
Stockholm 14
Boardman 13
Caserta 13
Hải Dương 13
Norwalk 13
Seoul 13
Tashkent 13
Brussels 12
Ninh Bình 12
Bangkok 11
Castelvetere sul Calore 11
Dhaka 11
Salvador 11
San Francisco 11
Addis Ababa 10
Belo Horizonte 10
Guangzhou 10
Mumbai 10
Totale 9.349
Nome #
Recent Advance in Biosensors for microRNAs Detection in Cancer 264
Nucleic acids in human glioma treatment: innovative approaches and recent results. 249
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway 185
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS 178
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 176
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 172
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 167
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer 166
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 166
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 162
PED regulates cell migration/invasion processes in human non small cell lung cancer cells through Rac1. 161
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 156
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects 154
Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells 153
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 152
Anti-breast cancer exosome aptamer for diagnostic and therapeutic uses 152
Therapeutic strategies to prevent contrast-induced acute kidney injury 151
Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study 146
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b 142
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer 142
Ultrasmall Carbon Nanodots as Theranostic Nanoheaters for Precision Breast Cancer Phototherapy: Establishing the Translational Potential in Tumor-in-a-Dish Models 139
Epigenetic Regulation of miR-212 Expression in Lung Cancer 138
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells 138
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. 136
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. 136
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. 136
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 134
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus 134
Optimisation of TAP-TAG purification in PED/PEA-15 interactoma studies 134
In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. 133
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay. 133
PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. 132
A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. 132
MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment 132
Contrast-induced acute kidney injury: Potential new strategies 131
Aptamer chimeras for therapeutic delivery: The challenging perspectives 131
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury 130
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 130
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRbeta Aptamer. 129
Targeting Insulin Receptor with a Novel Internalizing Aptamer 129
Potential and challenges of aptamers as specific carriers of therapeutic oligonucleotides for precision medicine in cancer 128
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity. 127
miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. 126
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. 124
"ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. 123
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. 123
Ex.50.T aptamer impairs tumor–stroma cross-talk in breast cancer by targeting gremlin-1 122
Modulating the crosstalk between the tumor and the microenvironment using sirna: A flexible strategy for breast cancer treatment 120
Predicting survival inss glioblastoma patients using diffusion mr imaging metrics—a systematic review 120
Novel Biomarkers for Contrast-Induced Acute Kidney Injury 119
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells 119
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 119
Urinary Dickkopf-3 and Contrast-Associated Kidney Damage 119
Antifouling strategies of nanoparticles for diagnostic and therapeutic application: A systematic review of the literature 118
Cell Death-based therapy 117
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. 116
Endothelial Progenitor Cells and Percutaneous Coronary Artery Intervention: Editorial to: “Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells after Percutaneous Coronary Intervention (HIPOCRATES Study)” by A. Eisen et al 115
RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY 115
Endothelial progenitor cells in coronary artery disease 113
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial. 113
Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine 113
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 113
Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. 112
Molecular basis of impaired insulin-stimulated cardiac glucose utilization in spontaneously hypertensive rats. 112
L’ipertrofia miocardia da sovraccarico pressorio induce un notevole incremento dell’espressione di C-Flip, una proteina indispensabile per lo sviluppo embrionale del cuore 112
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. 112
An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells. 112
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells 112
skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J. Biol. Chem. 272:7290-7297 IF: 5.581 (14) 110
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 110
Impact of microvascular complications on outcome after coronary stent implantations in diabetic patients 108
Insulin-activated PKCb bypasses Ras and stimulates MAPKinase activity and cell proliferation in muscle cells 108
miR221/222 in cancer: their role in tumor progression and response to therapy. 108
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications 108
SIROLIMUS-ELUTING STENT IMPLANTATION IN DIABETIC PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE 107
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 107
RenalGuard system in high-risk patients for contrast-induced acute kidney injury. 107
Combined targeting of glioblastoma stem-like cells by neutralizing RNA-bio-drugs for STAT3 107
IMPACT OF GLYCAEMIC AND LIPID CONTROL ON OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN DIABETIC PATIENTS. 105
La tirosino fosfatasi SHP-1 come nuovo marker prognostico del carcinoma mammario umano 105
The role of RNA and DNA aptamers in glioblastoma diagnosis and therapy: A systematic review of the literature 104
Functional importance of Insulin-like Growth Factor I receptor COOH-terminal region tyrosine phosphorylation sites. 103
Late INa Inhibition with Ranolazine Blunts Doxorubicin- Induced Cardiac Dysfunction and Remodeling in Mice 102
Insulin-like growth factor I receptor internalization regulates signaling via the Sch/Map kinase pathway, but not the insulin receptor substrate 1 pathway 102
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 102
Caratterizzazione dei meccanismi molecolari del danno indotto da mezzo di contrasto in cellule renali umane. 101
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. 101
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. 100
UTILITY OF 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN DIAGNOSIS OF LEFT VENTRICULAR DYSFUNCTION IN ANTI-ERBB2 THERAPY 100
Akt and Erk 8 activity regulation in cellular proliferation control 99
Autocrine production of IL-4 and IL-10 is required for survival and growth of thyroid cancer cells 98
Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27 rats 97
MicroRNAs signatures of TRAIL resistant phenotype in human non small cell lung cancer. 97
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. 97
Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients. 97
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. 97
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor 97
Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus 96
TNF-alfa signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alfa receptor 96
Nephrotoxicity of contrast media and protective effects of acetylcysteine. 96
Totale 12.627
Categoria #
all - tutte 54.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022879 53 1 1 7 46 35 10 32 129 57 133 375
2022/20231.121 165 78 34 72 137 132 5 104 195 134 47 18
2023/2024886 46 135 75 67 43 165 20 108 13 14 144 56
2024/20254.725 214 288 18 54 134 378 507 352 397 424 1.593 366
2025/20268.256 913 539 850 831 1.441 310 1.032 450 1.132 522 232 4
Totale 17.629